Lilly, Merck and Pfizer lead pharma's share price gains through 9 months: report

Lilly, Merck and Pfizer lead pharma's share price gains through 9 months: report

Source: 
Fierce Pharma
snippet: 

Biopharma investors have weathered some uncertain times in recent years, thanks in part to political and pricing pressure, but in 2018 the value of their holdings is largely growing. Several big drugmakers have posted double-digit share price gains in the first nine months of the year, as detailed in a report by Vantage, while other companies have seen only modest declines.